Back to results
US 2026/0217729 A1Published application
Halogen-substituted exatecan amide derivative, preparation method therefor, and use thereof
AssigneeHangzhou Adcoris Biopharma Co., Ltd
InventorsZhenwei MIAO, Yunsheng Huang
Life of this patent
Estimating the term…
Abstract
A halogen-substituted exatecan amide derivative, a preparation method therefor, and a use thereof are provided; the halogen-substituted exatecan amide derivative or a pharmaceutically acceptable salt, stereoisomer, or prodrug thereof has good cancer cell inhibitory activity and activity across the cell membrane, and can be applied to the treatment of cancer as a single drug, a combined drug, or a toxin component of an ADC.
Claims12
A compound of formula (I), or a pharmaceutically acceptable salt, a stereoisomer, or a prodrug thereof:
- in the Formula, R is selected from any one of C1-C6 alkyl, halogen-substituted C1-C6 alkyl,
- wherein, R1 is selected from C1-C6 alkylene, the C1-C6 alkylene is optionally substituted with one or more substituents selected from halogen, C1-C6 alkyl or halogen-substituted C1-C6 alkyl;
- R2 is selected from any one of halogen, C1-C6 alkyl or halogen-substituted C1-C6 alkyl;
- X is selected from any one of amino, imino.
1 more element
Dependencies are inferred from the claim text.